Cargando…

Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can lead to clinical manifestations of systemic diseases. Its leading features include chronic synovial inflammation and degeneration of the bones and joints. In the past decades, multiple susceptibilities for rheumatoid arthriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jianan, Jiang, Ping, Guo, Shicheng, Schrodi, Steven J., He, Dongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739882/
https://www.ncbi.nlm.nih.gov/pubmed/35003139
http://dx.doi.org/10.3389/fimmu.2021.809806
_version_ 1784629195537645568
author Zhao, Jianan
Jiang, Ping
Guo, Shicheng
Schrodi, Steven J.
He, Dongyi
author_facet Zhao, Jianan
Jiang, Ping
Guo, Shicheng
Schrodi, Steven J.
He, Dongyi
author_sort Zhao, Jianan
collection PubMed
description Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can lead to clinical manifestations of systemic diseases. Its leading features include chronic synovial inflammation and degeneration of the bones and joints. In the past decades, multiple susceptibilities for rheumatoid arthritis have been identified along with the development of a remarkable variety of drugs for its treatment; which include analgesics, glucocorticoids, nonsteroidal anti-inflammatory medications (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologic response modifiers (bDMARDs). Despite the existence of many clinical treatment options, the prognosis of some patients remains poor due to complex mechanism of the disease. Programmed cell death (PCD) has been extensively studied and ascertained to be one of the essential pathological mechanisms of RA. Its dysregulation in various associated cell types contributes to the development of RA. In this review, we summarize the role of apoptosis, cell death-associated neutrophil extracellular trap formation, necroptosis, pyroptosis, and autophagy in the pathophysiology of RA to provide a theoretical reference and insightful direction to the discovery and development of novel therapeutic targets for RA.
format Online
Article
Text
id pubmed-8739882
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87398822022-01-08 Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis Zhao, Jianan Jiang, Ping Guo, Shicheng Schrodi, Steven J. He, Dongyi Front Immunol Immunology Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can lead to clinical manifestations of systemic diseases. Its leading features include chronic synovial inflammation and degeneration of the bones and joints. In the past decades, multiple susceptibilities for rheumatoid arthritis have been identified along with the development of a remarkable variety of drugs for its treatment; which include analgesics, glucocorticoids, nonsteroidal anti-inflammatory medications (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologic response modifiers (bDMARDs). Despite the existence of many clinical treatment options, the prognosis of some patients remains poor due to complex mechanism of the disease. Programmed cell death (PCD) has been extensively studied and ascertained to be one of the essential pathological mechanisms of RA. Its dysregulation in various associated cell types contributes to the development of RA. In this review, we summarize the role of apoptosis, cell death-associated neutrophil extracellular trap formation, necroptosis, pyroptosis, and autophagy in the pathophysiology of RA to provide a theoretical reference and insightful direction to the discovery and development of novel therapeutic targets for RA. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8739882/ /pubmed/35003139 http://dx.doi.org/10.3389/fimmu.2021.809806 Text en Copyright © 2021 Zhao, Jiang, Guo, Schrodi and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhao, Jianan
Jiang, Ping
Guo, Shicheng
Schrodi, Steven J.
He, Dongyi
Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
title Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
title_full Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
title_fullStr Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
title_full_unstemmed Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
title_short Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
title_sort apoptosis, autophagy, netosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739882/
https://www.ncbi.nlm.nih.gov/pubmed/35003139
http://dx.doi.org/10.3389/fimmu.2021.809806
work_keys_str_mv AT zhaojianan apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis
AT jiangping apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis
AT guoshicheng apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis
AT schrodistevenj apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis
AT hedongyi apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis